111 related articles for article (PubMed ID: 28121669)
21. High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy.
Piketty C; Darragh TM; Heard I; Da Costa M; Bruneval P; Kazatchkine MD; Palefsky JM
Sex Transm Dis; 2004 Feb; 31(2):96-9. PubMed ID: 14743072
[TBL] [Abstract][Full Text] [Related]
22. The impact of highly active antiretroviral therapy on prevalence and incidence of cervical human papillomavirus infections in HIV-positive adolescents.
Shrestha S; Sudenga SL; Smith JS; Bachmann LH; Wilson CM; Kempf MC
BMC Infect Dis; 2010 Oct; 10():295. PubMed ID: 20946655
[TBL] [Abstract][Full Text] [Related]
23. Oral human papillomavirus infection in men might contribute to HPV serology.
Syrjänen S; Waterboer T; Kero K; Rautava J; Syrjänen K; Grenman S; Pawlita M
Eur J Clin Microbiol Infect Dis; 2015 Feb; 34(2):237-45. PubMed ID: 25116322
[TBL] [Abstract][Full Text] [Related]
24. Antibody responses following incident anal and penile infection with human papillomavirus in teenage men who have sex with men.
Zou H; Tabrizi SN; Grulich AE; Hocking JS; Garland SM; Bradshaw CS; Cornall AM; Fairley CK; Chen MY
Int J Cancer; 2016 Aug; 139(3):639-46. PubMed ID: 26991809
[TBL] [Abstract][Full Text] [Related]
25. Timing of HPV16-E6 antibody seroconversion before OPSCC: findings from the HPVC3 consortium.
Kreimer AR; Ferreiro-Iglesias A; Nygard M; Bender N; Schroeder L; Hildesheim A; Robbins HA; Pawlita M; Langseth H; Schlecht NF; Tinker LF; Agalliu I; Smoller SW; Ness-Jensen E; Hveem K; D'Souza G; Visvanathan K; May B; Ursin G; Weiderpass E; Giles GG; Milne RL; Cai Q; Blot WJ; Zheng W; Weinstein SJ; Albanes D; Brenner N; Hoffman-Bolton J; Kaaks R; Barricarte A; Tjønneland A; Sacerdote C; Trichopoulou A; Vermeulen RCH; Huang WY; Freedman ND; Brennan P; Waterboer T; Johansson M
Ann Oncol; 2019 Aug; 30(8):1335-1343. PubMed ID: 31185496
[TBL] [Abstract][Full Text] [Related]
26. Human Papillomavirus Seroprevalence and Association with Anal HPV Infection and Squamous Intraepithelial Lesions in Australian Gay and Bisexual Men.
Poynten IM; Waterboer T; Jin F; Templeton DJ; Hillman RJ; Law C; Cornall A; Tabrizi S; Roberts JM; Garland SM; Fairley CK; Grulich AE
Cancer Epidemiol Biomarkers Prev; 2018 Jul; 27(7):768-775. PubMed ID: 29700009
[No Abstract] [Full Text] [Related]
27. Antibodies against HPV16E6 oncoprotein in the Swiss HIV cohort study: Kinetics and anal cancer risk prediction.
Combes JD; Clifford GM; Günthard HF; Hauser C; Darling KEA; Valladares P; Battegay M; Waldeck F; Bernasconi E; Bertisch B; Hirsch HH; Brenner N; Waterboer T; Scherrer AU;
Int J Cancer; 2020 Aug; 147(3):757-765. PubMed ID: 31722114
[TBL] [Abstract][Full Text] [Related]
28. Human Papillomavirus (HPV) 16 E6 seropositivity is elevated in subjects with oral HPV16 infection.
Zhang Y; Waterboer T; Pawlita M; Sugar E; Minkoff H; Cranston RD; Wiley D; Burk R; Reddy S; Margolick J; Strickler H; Weber K; Gillison M; D'Souza G
Cancer Epidemiol; 2016 Aug; 43():30-4. PubMed ID: 27344614
[TBL] [Abstract][Full Text] [Related]
29. Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma.
Holzinger D; Wichmann G; Baboci L; Michel A; Höfler D; Wiesenfarth M; Schroeder L; Boscolo-Rizzo P; Herold-Mende C; Dyckhoff G; Boehm A; Del Mistro A; Bosch FX; Dietz A; Pawlita M; Waterboer T
Int J Cancer; 2017 Jun; 140(12):2748-2757. PubMed ID: 28316084
[TBL] [Abstract][Full Text] [Related]
30. Natural history of human papillomavirus infections involving anal, penile, and oral sites among HIV-positive men.
Videla S; Darwich L; Cañadas MP; Coll J; Piñol M; García-Cuyás F; Molina-Lopez RA; Cobarsi P; Clotet B; Sirera G;
Sex Transm Dis; 2013 Jan; 40(1):3-10. PubMed ID: 23250297
[TBL] [Abstract][Full Text] [Related]
31. No evidence for a protective effect of naturally induced HPV antibodies on subsequent anogenital HPV infection in HIV-negative and HIV-infected MSM.
Mooij SH; Landén O; van der Klis FR; van der Sande MA; de Melker HE; Coutinho RA; van Eeden A; van Rooijen MS; Meijer CJ; Schim van der Loeff MF
J Infect; 2014 Oct; 69(4):375-86. PubMed ID: 24931579
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of human papillomavirus in men who have sex with men in the era of an effective vaccine; a call to act.
Sadlier C; Rowley D; Morley D; Surah S; O'Dea S; Delamere S; O'Leary J; Smyth P; Clarke S; Sheils O; Bergin C
HIV Med; 2014 Sep; 15(8):499-504. PubMed ID: 24655896
[TBL] [Abstract][Full Text] [Related]
33. Post-treatment human papillomavirus antibody kinetics in cervical cancer patients.
Piontek T; Harmel C; Pawlita M; Carow K; Schröter J; Runnebaum IB; Dürst M; Graw F; Waterboer T
Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1773):20180295. PubMed ID: 30955486
[TBL] [Abstract][Full Text] [Related]
34. Human papillomavirus antibodies and future risk of anogenital cancer: a nested case-control study in the European prospective investigation into cancer and nutrition study.
Kreimer AR; Brennan P; Lang Kuhs KA; Waterboer T; Clifford G; Franceschi S; Michel A; Willhauck-Fleckenstein M; Riboli E; Castellsagué X; Hildesheim A; Fortner RT; Kaaks R; Palli D; Ljuslinder I; Panico S; Clavel-Chapelon F; Boutron-Ruault MC; Mesrine S; Trichopoulou A; Lagiou P; Trichopoulos D; Peeters PH; Cross AJ; Bueno-de-Mesquita HB; Vineis P; Larrañaga N; Pala V; Sánchez MJ; Navarro C; Barricarte A; Tumino R; Khaw KT; Wareham N; Boeing H; Steffen A; Travis RC; Quirós JR; Weiderpass E; Pawlita M; Johansson M
J Clin Oncol; 2015 Mar; 33(8):877-84. PubMed ID: 25667279
[TBL] [Abstract][Full Text] [Related]
35. Risk factors for anal HPV-16/18 infection in Mexican HIV-infected men who have sex with men.
Torres-Ibarra L; Conde-Glez CJ; Salmerón J; Palefsky J; Hernández-Nevares P; Sánchez-Alemán MA; Magis-Rodríguez C; Lazcano-Ponce E
Prev Med; 2014 Dec; 69():157-64. PubMed ID: 25251099
[TBL] [Abstract][Full Text] [Related]
36. Anal and penile high-risk human papillomavirus prevalence in HIV-negative and HIV-infected MSM.
van Aar F; Mooij SH; van der Sande MA; Speksnijder AG; Stolte IG; Meijer CJ; Verhagen DW; King AJ; de Vries HJ; Schim van der Loeff MF
AIDS; 2013 Nov; 27(18):2921-31. PubMed ID: 23921617
[TBL] [Abstract][Full Text] [Related]
37. Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa Rica.
Coseo S; Porras C; Hildesheim A; Rodriguez AC; Schiffman M; Herrero R; Wacholder S; Gonzalez P; Wang SS; Sherman ME; Jimenez S; Solomon D; Bougelet C; van Doorn LJ; Quint W; Safaeian M;
Sex Transm Dis; 2010 Nov; 37(11):706-14. PubMed ID: 20661178
[TBL] [Abstract][Full Text] [Related]
38. Distribution of human papillomavirus genotypes in anal cytological and histological specimens from HIV-infected men who have sex with men and men who have sex with women.
Darwich L; Videla S; Cañadas MP; Piñol M; García-Cuyàs F; Vela S; Molina-López RA; Coll J; Sirera G; Clotet B;
Dis Colon Rectum; 2013 Sep; 56(9):1043-52. PubMed ID: 23929013
[TBL] [Abstract][Full Text] [Related]
39. Influence of adherent and effective antiretroviral therapy use on human papillomavirus infection and squamous intraepithelial lesions in human immunodeficiency virus-positive women.
Minkoff H; Zhong Y; Burk RD; Palefsky JM; Xue X; Watts DH; Levine AM; Wright RL; Colie C; D'Souza G; Massad LS; Strickler HD
J Infect Dis; 2010 Mar; 201(5):681-90. PubMed ID: 20105077
[TBL] [Abstract][Full Text] [Related]
40. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
